Digitalis-based drugs like digoxin have been used for centuries to treat patients with irregular heart rhythms and heart failure and are still in use today. In the Dec.…

Researchers have discovered two enzymes that, when combined, could be involved in the earliest stages of cancer. Manipulating these enzymes genetically might lead to targeted therapies aimed at…

Cancer could snuff out 1 billion lives this century. That was one of several chilling statistics revealed at a news conference at the American Cancer Society on Tuesday in Atlanta.

The…

One day Gisele Bigras was a college student finishing up another year of school. The next day, she was a cancer patient faced with having one of her fingers removed.

An international coalition of pediatric cancer physicians and researchers has developed new systems to standardize studies of neuroblastomas across the world. In the December issue…

Although some teenagers and young adults become infertile following cancer treatment, physicians are hesitant to discuss options to preserve fertility with patients, according to a new Florida…

Researchers at the University of California, San Diego School of Medicine, led by Ajit Varki, M.D., have shown a new mechanism for how human consumption of red meat and…

Many newly diagnosed cancer patients, no matter what their age, have trouble absorbing all the information their doctors give them, a new study shows.

The findings, which appear in…

News articles that stress African-American health disparities, like higher cancer mortality rates than other groups, may discourage black patients from being screened…

From the sun’s UVA rays to tobacco smoke, our environment is chock-full of DNA-damaging agents that can lead to cancer. Thanks to our body’s DNA repair mechanisms, however, the…

Physicians at The Methodist Hospital in Houston are studying ways to use magnetic resonance imaging (MRI) and ultrasound to relieve some of the most intense pain resulting from cancer that has…

For the first time, scientists have decoded the complete DNA of a cancer patient and traced her disease - acute myelogenous leukemia - to its genetic roots.…

A very difficult-to-treat child leukemia may benefit from the discovery of a small but potent epigenetic change that launches the cancer – but could potentially be reversed relatively…

A very difficult-to-treat child leukemia may benefit from the discovery of a small but potent epigenetic change that launches the cancer – but could potentially be reversed relatively…

A team of scientists at Arkansas Nanotechnology Center at UALR (the University of Arkansas at Little Rock) has developed what promises to be a non-invasive method of eradicating cancer cells while…

Like a sentry guarding the castle walls, a molecular messenger inside adult stem cells sounds the alarm when it senses hazards that could allow…

Cancer incidence is higher among liver transplant recipients in Finland compared to the general population, according to a new study in the October issue of Liver…

Researchers at the University of Pennsylvania School of Medicine have found that some proteins of the immune system can promote tumor growth. Investigators found that…

Three enzymes called phosphatases that shut down a molecule called SRC-3 (steroid receptor coactivator 3) could provide a new pathway for fighting cancer, particularly tumors of the breast and prostate, said researchers…

University of Iowa researchers have developed a new imaging approach for identifying a rare form of thyroid cancer that is typically hard to diagnose. Accurate diagnosis of the cancer, known…

Biologists at the University of Rochester have found that small-bodied rodents with long lifespans have evolved a previously unknown anti-cancer mechanism that appears to be different from any anticancer mechanisms…

Researchers at the Medical College of Wisconsin in Milwaukee have a pending patent on a new synthetic form of a protein involved in certain types of…

New research has highlighted stark disparities in access to the latest cancer drugs across European Union nations, according to data presented at the 33rd Congress of the European Society for…

Although cancer remains a leading cause of death in America, it can take up to 12 years to bring a new anti-cancer agent before the FDA and the success…

A new glimpse at how cells respond to certain chemotherapy drugs may help clinicians understand why some tumors re-grow after treatment – and why drugs that block blood vessel…